Cited by 853Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismHistorical Medical Research and Treatments

The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.

The discovery and development of HMG-CoA reductase inhibitors.

Open access

Endo, A·1992·Journal of Lipid Research

DOI 10.1016/s0022-2275(20)41379-3

Open this paper in CoChat — free account

Abstract

During the 1950s and 1960s, many cholesterol-lowering agents were reported and introduced into clinical use, in-

Integrity signals

Registry

Crossref · 10.1016/s0022-2275(20)41379-3

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
Goldstein, L. J., & Brown, S. M. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.004341 · Cited by 1,906
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
Alberts, A. W., Chen, J., Kuron, G. W., Hunt, V. M., Huff, J. W., Hoffman, C., Rothrock, J. W., López, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,630
Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-786_2 · Cited by 1,426
ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.
Endo, A., KURODA, M., & Tsujita, Y. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1346 · Cited by 954
Self-citation
Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
Endo, A., Kuroda, M., & Tanzawa, K. (1976) · FEBS Letters · doi:10.1016/0014-5793(76)80996-9 · Cited by 800
Self-citation
HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
Oates, J. A., Wood, A. J. J., & Grundy, S. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807073190105 · Cited by 760
Influence of nicotinic acid on serum cholesterol in man
Altschul, R., Hoffer, A., & Stephen, J. D. (1955) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(55)90070-9 · Cited by 726

Show all 114 references

Research works printed but not linked: 5

1988, The Lipid Research Clinics Coronary Primary Prevention Trial Results. 1. Reduction in the incidence of coronary heart disease, JAMA., 251, 351
Taupitz, 1959, The effects of estrogens on the serum cholesterol of male rats, Symp. Deut. Ges. En-dokrinol., 430
Endo, 1978, Effects of ML-236B, a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase, on cholesterol metabolism, Adv. Exp. Med. Biol., 109, 376
Shigematsu, 1979, Treatment of hypercholesterolemia with an HMG-CoA reductase inhibitor (CS-500). I. Phase I study in normal subjects, Geriat. Med. (Japan)., 17, 1564
Alberts, 1988, Lovastatin and simvastatin, Cah. Nutr. Diet., 23, 231

Sorted by citations

Items 501–600 of 853

Statins and Blood Pressure: Is There an Effect or Not?
Sarafidis, P. A., Kanaki, A., & Lasaridis, A. N. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06625.x · Cited by 10
Repurposing of Metabolic Drugs and Mitochondrial Modulators as an Emerging Class of Cancer Therapeutics with a Special Focus on Breast Cancer
Tripathi, V., Jaiswal, P., Sahu, K., Majumder, S. K., Kashyap, D., Jha, H. C., Dixit, A. K., & Parmar, H. S. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100065 · Cited by 9
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine
Kapturska, K., & Pawlak, A. (2023) · Veterinary and Comparative Oncology · doi:10.1111/vco.12917 · Cited by 9
Harnessing the Power of Natural Products for Targeted Protein Degradation
Zhu, B., Wu, Z., Shou, Y., Zhao, K., Lu, Q., Qin, J., & Guo, H. (2025) · Medicinal Research Reviews · doi:10.1002/med.22113 · Cited by 12
Translational research: Lessons from past research, growing up nowadays, and development goal in future
Zhang, Z., Chen, H., & Liu, D. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4252-0 · Cited by 9
RETRACTED: Statins significantly repress rotavirus replication through downregulation of cholesterol synthesis
Ding, S., Yu, B., & van Vuuren, A. J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1955643 · Cited by 9
Retracted
Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment
Shah, U., Shah, A., Patel, S. P., Patel, A., Patel, M. M., Solanki, N. D., Patel, S., Patel, A. D., Patel, V., & Patel, B. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221005124808 · Cited by 10
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
Jesús‐González, L. A. D., del Ángel, R. M., Palacios-Rápalo, S. N., Cordero‐Rivera, C. D., Rodríguez-Carlos, A., Trujillo-Páez, J. V., Farfán-Morales, C. N., Osuna‐Ramos, J. F., Reyes-Ruíz, J. M., Rivas-Santiago, B. T., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12020383 · Cited by 9
Structural insight for substrate tolerance to 2-deoxyribose-5-phosphate aldolase from the pathogen Streptococcus suis
Cao, T.-P., Kim, J.-S., Woo, M.-H., Choi, J. M., Jun, Y., Lee, K. H., & Lee, S. H. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-6029-4 · Cited by 9
Diabetogenic effect of pravastatin is associated with insulin resistance and myotoxicity in hypercholesterolemic mice
Lorza‐Gil, E., García‐Arévalo, M., Favero‐Santos, B. C., Gomes‐Marcondes, M. C. C., & Oliveira, H. C. F. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2045-6 · Cited by 10
Drug Discovery and Target Identification against Schistosomiasis: A Reality Check on Progress and Future Prospects
Cheuka, P. M. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666210924101805 · Cited by 11
Experimental and Computation Studies on Candida antarctica Lipase B‐Catalyzed Enantioselective Alcoholysis of 4‐Bromomethyl‐β‐lactone Leading to Enantiopure 4‐Bromo‐3‐hydroxybutanoate
Lim, J. Y., Jeon, N. Y., Park, A., Min, B., Kim, B., Park, S., & Lee, H. (2013) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201200901 · Cited by 9
Clinical Relevance of Target Identity and Biology: Implications for Drug Discovery and Development
Patel, A. C. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113505906 · Cited by 9
FR901512, a Novel HMG-CoA Reductase Inhibitor Produced by an Agonomycetous Fungus No. 14919: II. Biological Profiles
Hatori, H., Sato, B., SATO, I., Shibata, T., Ueda, H., Hino, M., & Fujii, T. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.390 · Cited by 9
Statins
McKenney, J. M., Ganz, P., Wiggins, B. S., & Saseen, J. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50026-3 · Cited by 10
Functional Evidence For Anti‐Oxidant Action Of Fluvastatin On Low‐Density Lipoprotein Using Isolated Macrophages And Aorta
Kagota, S., Yamaguchi, Y., Nakamura, K., & Kunitomo, M. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03246.x · Cited by 9
The Combined Inhibition of SREBP and mTORC1 Signaling Synergistically Inhibits B‐Cell Lymphoma
Zhu, Z., Jiang, W., Zhou, J., Maldeney, A. R., Liang, J., Yang, J., & Luo, W. (2024) · Cancer Medicine · doi:10.1002/cam4.70342 · Cited by 8
Research on the Efficient Enantioselective Total Synthesis of Useful Bioactive Polycyclic Compounds
Nakada, M. (2022) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20210329 · Cited by 8
Doble inhibición del colesterol: papel de la regulación intestinal y hepática
Ros, E. (2006) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(06)75329-8 · Cited by 8
Atorvastatin Reduces High Glucose Toxicity in Rat Peritoneal Mesothelial Cells
Carrión, B., Pérez‐Martínez, F. C., Monteagudo, S., Pérez‐Carrión, M. D., Gómez‐Roldán, C., Ceña, V., & Pérez‐Martínez, J. (2011) · Peritoneal Dialysis International · doi:10.3747/pdi.2010.00164 · Cited by 8
Biodegradable Polymers Influence the Effect of Atorvastatin on Human Coronary Artery Cells
Strohbach, A., Begunk, R., Petersen, S., Felix, S. B., Sternberg, K., & Busch, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020148 · Cited by 8
Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells
Kobayashi, K., Baba, K., Kambayashi, S., & Okuda, M. (2020) · Veterinary and Comparative Oncology · doi:10.1111/vco.12644 · Cited by 8
HMG-CoA Reductase Inhibitors for Traumatic Brain Injury
Katlowitz, K. A., Gopinath, S. P., Navarro, J. C., & Robertson, C. S. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01399-9 · Cited by 8
Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype
Dergunov, A. D., Nv, P., Visvikis‐Siest, S., & Siest, G. (2003) · Vascular Pharmacology · doi:10.1016/j.vph.2003.09.002 · Cited by 8
Synthesis, characterization and pharmacological evaluation of certain sulfonamide containing heterocyclic motifs
Kumar, B. S., Aluru, R. G. P., Reddy, P. R., & Ravindranath, L. R. K. R. (2014) · Polish Annals of Medicine · doi:10.1016/j.poamed.2014.07.006 · Cited by 8
Effects of atorvastatin 10 mg and simvastatin 20 mg on serum triglyceride levels in patients with hypercholesterolemia
Branchi, A., Fiorenza, A. M., Torri, A., Muzio, F., Rovellini, A., Berra, C., & Sommariva, D. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)89005-6 · Cited by 8
FR171456, a Novel Cholesterol Synthesis Inhibitor Produced by Sporormiella minma No. 15604: I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties
Hatori, H., Shibata, T., TSURUMI, Y., Nakanishi, T., Katsuoka, M., OHTSU, Y., Sakamoto, K., Takase, S., Ueda, H., Hino, M., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.253 · Cited by 8
Dyslipidemia Part 2
Gonzalez, L., Helkin, A. W., & Gahtan, V. (2016) · Vascular and Endovascular Surgery · doi:10.1177/1538574416628655 · Cited by 8
Asymmetric Total Syntheses of Two 3-Acyl-5,6- dihydro-2H-pyrones: (R)-Podoblastin-S and (R)- Lachnelluloic Acid with Verification of the Absolute Configuration of (−)-Lachnelluloic Acid
Fujiwara, T., Tsutsumi, T., Nakata, K., Nakatsuji, H., & Tanabe, Y. (2017) · Molecules · doi:10.3390/molecules22010069 · Cited by 8
[Updates on rickets and osteomalacia: guidelines for diagnosis of rickets and osteomalacia].
Ohata, Y., & Ozono, K. (2013) · PubMed · Cited by 8
Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus
Kazumi, T., Yoshino, G., Ishida, Y., IWATANI, I., Morita, S., Tateiwa, M., & Kasuga, M. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)01019-v · Cited by 8
BAYw6228 suppresses accumulation of macrophages in balloon-induced intimal thickening of rabbit carotid artery
Igarashi, M., Takeda, Y., Mori, S., Ishibashi, N., 小松, 栄., Takahashi, K., Fuse, T., Yamamura, M., Sugiyama, Y., & Saito, Y. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06017-0 · Cited by 8
Simultaneous Determination and Drug Dissolution Testing of Combined Amlodipine Tablet Formulations Using RP-LC
Özkan, C. K., Kurbanoğlu, S., Eşi̇m, Ö., Savaşer, A., Özkan, S. A., & Özkan, Y. (2016) · Chromatographia · doi:10.1007/s10337-016-3125-x · Cited by 7
Synthesis and characterization of Rosuvastatin calcium impurity A; a HMG-CoA reductase inhibitor
Lee, Y. H., Viji, M., Lee, E., Jo, H., Yoo, K., Sim, J., Lee, S., Lee, K., Lee, H., & Jung, J. (2017) · Tetrahedron Letters · doi:10.1016/j.tetlet.2017.05.075 · Cited by 7
Mevalonate Pathway in Bacteria and Archaea
Kuzuyama, T., Hemmi, H., & Takahashi, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.02728-1 · Cited by 7
Erectcyanthins A-C from marine sponge Hyrtios erectus : anti-dyslipidemic agents attenuate hydroxymethylglutaryl coenzyme A reductase
Chakraborty, K., & Francis, P. (2021) · Natural Product Research · doi:10.1080/14786419.2021.2013216 · Cited by 7
Cholesterol absorption inhibitors in development as potential therapeutics
Takekoshi, N., & Kajinami, K. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.6.831 · Cited by 7
SCREENING OF HMG CO A REDUCTASE INHIBITOR PRODUCING MARINE ACTINOMYCETES
Srinu, P. B. (2010) · Asian Journal of Pharmaceutical Research and Health Care · Cited by 7
Adaptation to statins restricts human tumour growth in Nude mice
Follet, J., Rémy, L., Hesry, V., Simon, B., Gillet, D., Auvray, P., Corcos, L., & Jossic-Corcos, C. L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-491 · Cited by 7
The Potential Effect of Statins on Rituximab Immunotherapy
Cragg, M. S. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050077 · Cited by 7
Review: Cardiovascular & Renal Recent developments in hypocholesterolaemic agents
Lee, H. T., & Picard, J. A. (1995) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.5.5.397 · Cited by 7
Implementing green chemistry for synthesis of cholesterol-lowering statin drugs
Basak, A., & Basak, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817592-7.00016-2 · Cited by 5
l-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats
Murad, H. A. S. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500065 · Cited by 6
The effect of retinoic acid receptor agonist acitretin on the production of bile and concentrations of some serum components in ovariectomized rats
Czerny, B., Teister, M., Juzyszyn, Z., Teister, Ł., Pawlik, A., Gazda, P., Kamiński, A., & Chałas, A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ef22b8 · Cited by 6
Review of Recent Laboratory and Experimental Data on Cardiotoxicity of Statins
Chaulin, A. M. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9110403 · Cited by 6
The effect of simvastatin treatment on endothelial cell response to shear stress and tumor necrosis factor alpha stimulation
Dick, M., MacDonald, K. N., Tardif, J., & Leask, R. L. (2015) · BioMedical Engineering OnLine · doi:10.1186/s12938-015-0057-x · Cited by 6
Efectos no hipolipemiantes de las estatinas
Ramos-Esquivel, A., & Céspedes, C. L. (2009) · Acta Médica Costarricense · doi:10.51481/amc.v49i4.330 · Cited by 12
Effect of the statin therapy on biochemical laboratory tests—A chemometrics study
Ďurčeková, T., Mocák, J., Boronová, K., & Balla, J. (2010) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2010.07.047 · Cited by 6
Effects of Combined Prednisone + Fluvastatin on Cholesterol and Bilirubin in Pediatric Patients With Minimal Change Nephropathy
Song, M., An-jun, L., Gong, J., Yang, D., Ma, L., Zhou, X., Yan, Y., & Xie, Y. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.02.001 · Cited by 6
Pharmacogenomics in the Development and Characterization of Atheroprotective Drugs
Valanti, E., Tsompanidis, A., & Sanoudou, D. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0956-8_11 · Cited by 6
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Yang, J., Wong, L.-Y., Tian, X.-Y., Wei, R., Lai, W., Au, K., Luo, Z., Ward, C., Ho, W.-I., Ibañez, D. P., et al. (2018) · Journal of Visualized Experiments · doi:10.3791/57556 · Cited by 6
Cardiovascular medication changes over 5 years in a national data linkage study: implications for risk prediction models
Mehta, S., Jackson, R., Wells, S., Harrison, J., Exeter, D. J., & Kerr, A. (2018) · Clinical Epidemiology · doi:10.2147/clep.s138100 · Cited by 6
Dyslipidemia: Genetics and Role in the Metabolic Syndrome
Nora, L., & Pillai, A. L. P. C. (2012) · InTech eBooks · doi:10.5772/28188 · Cited by 7
Atorvastatin is not cataractogenic in beagle dogs
Robertson, D. G., Urda, E. R., Rothwell, C. E., & Walsh, K. M. (1997) · Current Eye Research · doi:10.1076/ceyr.16.12.1229.5035 · Cited by 6
The Case for Early Statin Therapy in Acute Coronary Syndromes
Arntz, H.-R. (2002) · Cardiology in Review · doi:10.1097/00045415-200203000-00007 · Cited by 6
REASSURING EFFECT OF PRAVASTATIN ON NATURAL KILLER CELL ACTIVITY IN STABLE RENAL TRANSPLANT PATIENTS
Vaessen, L. M. B., van Miert, P. P. M. C., van Gelder, T., IJzermans, J. N. M., & Weimar, W. W. (2001) · Transplantation · doi:10.1097/00007890-200104270-00028 · Cited by 6
Novel 1,4-diarylpiperidine-4-methylureas as anti-hyperlipidemic agents: Dual effectors on acyl-CoA:cholesterol O-acyltransferase and low-density lipoprotein receptor expression
Asano, S., Ban, H., Kino, K., Ioriya, K., & Muraoka, M. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.020 · Cited by 6
Recent Progress in the Synthesis of Super-Statins
Časar, Z. (2015) · Topics in heterocyclic chemistry · doi:10.1007/7081_2015_189 · Cited by 6
Statin therapy improves locomotor muscle microvascular reactivity in patients with heart failure with preserved ejection fraction
Iacovelli, J. J., Alpenglow, J. K., Ratchford, S. M., Craig, J. C., Simmons, J. M., Zhao, J., Reese, V. R., Bunsawat, K., Ma, C. L., Ryan, J. J., et al. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00427.2024 · Cited by 5
The Potential Therapeutic Applications of Natural Products in the Oxidative Stress-Related MVA Pathway: Focus on HMGCR
Teng, Y. (2025) · Antioxidants · doi:10.3390/antiox14081001 · Cited by 5
Evaluation Of Anti-Hyperlipidemic Potentials Of Aqueous Fruit Pulp Extract Of Adensonia Digitata In Experimental Rats
Alhassan, A. J., Muhammad, I. U., Jarumi, I. K., & Wudil, A. (2016) · European Scientific Journal ESJ · doi:10.19044/esj.2016.v12n12p298 · Cited by 5
Can statins lessen the burden of virus mediated cancers?
Clark, E. H., Ahmed, S. T., Chang, E., Chiao, E. Y., & White, D. L. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-022-00460-0 · Cited by 5
Blockade of isoprenoids biosynthesis by simvastatin induces autophagy-mediated cell death via downstream c-Jun N-terminal kinase activation and cell cycle dysregulation in canine T-cell lymphoma cells
Kobayashi, K., Baba, K., Kambayashi, S., & Okuda, M. (2024) · Research in Veterinary Science · doi:10.1016/j.rvsc.2024.105174 · Cited by 5
Treatment of Homozygous Familial Hypercholesterolemia
Cegla, J., Walji, S., Barton, L., Neuwirth, C. K. Y., & Thompson, G. R. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101708 · Cited by 6
Optimal Treatment of Extracranial Carotid Artery Disease: Carotid Endarterectomy, Carotid Stenting, or Optimal Medical Therapy
Rogers, R. K., & Bishu, K. G. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0636-2 · Cited by 5
High-dose lovastatin decreased basal prostacyclin production in cultured endothelial cells
Zhou, Q. X., Zhou, Y., & Kummerow, F. A. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.005 · Cited by 5
Advances in the bioconversion mechanism of lovastatin to wuxistatin by Amycolatopsis sp. CGMCC 1149
Zong, H., Zhuge, B., Fang, H., Yanhui, C., Lin, M., Fu, W., Song, J., & Zhuge, J. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4341-4 · Cited by 5
Lipids and cardiovascular disease 3 Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · Cited by 5
Development of a Practical and Efficient Synthesis of SIPI-4884, a HMG CoA Reductase Inhibitor for the Treatment of Hypercholesterolemia
Hao, Q., Pan, J., Li, Y., Cai, Z., & Zhou, W. (2013) · Organic Process Research & Development · doi:10.1021/op400060z · Cited by 5
Carotid surgery today: An update after 14,000 carotid endarterectomy procedures
Radak, D. J., Ilijevski, N. S., & Djukic, N. (2016) · Vojnosanitetski pregled · doi:10.2298/vsp160305060r · Cited by 5
Antidyslipidemic potential of a novel farnesoid X receptor antagonist in a hamster model of dyslipidemia: Comparative studies of other nonstatin agents
Shinozawa, E., Amano, Y., Yamakawa, H., Haba, M., Shimada, M., & Tozawa, R. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.390 · Cited by 5
Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous origin
Bonnefont‐Rousselot, D., Benouda, L., Bittar, R., Darabi, M., Demondion, P., Lesnik, P., Leprince, P. N., Kontush, A., Charniot, J., & Giral, P. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.07.022 · Cited by 5
Apolipoprotein E Mimetic Peptides: Cholesterol-Dependent and Cholesterol-Independent Properties
Garber, D. W., Goldberg, D., & Anantharamaiah, G. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17350-4_10 · Cited by 5
Dyslipidemia and bone metabolism. A common bond of the osteoporosis and the atherosclerosis
Hernández, J. L., Martínez, O., & González Macías, J. (2011) · Cited by 5
Synthesis and Anti‐Hypercholesterolemic Evaluations of Calcium Salts of 4‐Substituted Quinoline‐Based Mevalonic Acid
Hao, Q., Cai, Z., Pan, J., Li, Y., Xia, Y., Min, Y., Sheng, Y., & Zhou, W. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01198.x · Cited by 5
Cholesterol Improvement Synergistic Effects of Fermented Soybean Grits Caused by Added with Mung Bean in vitro
Lee, S., Kim, H., Yu, M.-H., Lee, E.-J., Lee, S., & Lee, I.-S. (2010) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2010.39.7.947 · Cited by 5
Effects of statins on lipoprotein fractions
Cortese, C., & Liberatoscioli, L. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00787-8 · Cited by 5
Thyroid mimetic as an option for lowering low-density lipoprotein
Grundy, S. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705959104 · Cited by 5
Enzyminhibitoren als Arzneistoffe Teil I
Nuhn, P. (1997) · Pharmazie in unserer Zeit · doi:10.1002/pauz.19970260306 · Cited by 5
Fighting high cholesterol levels — lipid lowering drugs
Fidge, N. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141361.x · Cited by 5
Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives
Villa, R. F., Ferrari, F., & Moretti, A. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3_14 · Cited by 5
Lifibrol: first member of a new class of lipid-lowering drugs?
Scharnagl, H., MTMrz, W., & Wieland, H. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.5.583 · Cited by 5
Effects of Simvastatin on Plasma Lipoprotein Concentrations and Very-Low-Density Lipoprotein Secretion in the Rat.
Sérougne, C., Mathé, D., Férézou, J., Bertin, C., Riottot, M., Lutton, C., & JACOTOT, B. (1995) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.18.55 · Cited by 5
Impact of statins in the liver: A bane or a boon?
Zacharia, G. S., Jacob, A., Karichery, M., & Sasidharan, A. (2024) · Canadian Liver Journal · doi:10.3138/canlivj-2023-0028 · Cited by 5
Anogeissus Latifolia : A Comprehensive Review from Ethanobotanical Insights to Future Pharmacological Frontiers
Khan, S. A., Ahsan, F., Mahmood, T., & Bano, S. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202401378 · Cited by 4
Association of Meibomian Gland Dysfunction with Oral Statin Use
Park, S., Lee, J., Hwang, H., Kim, H. S., Han, K., & Na, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154632 · Cited by 4
Evolving concepts of low‐density lipoprotein: From structure to function
Chen, C., Sawamura, T., Akhmedov, A. T., Tsai, M., Akyol, Ö., Kakino, A., Chiang, H., Kraler, S. C., & Lüscher, T. F. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70019 · Cited by 6
Pitavastatin: The Newest HMG-CoA Reductase Inhibitor
Watson, K. E. (2010) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0535 · Cited by 4
Efficient and highly stereoselective assembly of rosuvastatin
Šterk, D., Zaugg, W., Beutler, U., Loeser, E., Prasad, K., & Časar, Z. (2016) · Tetrahedron Letters · doi:10.1016/j.tetlet.2016.02.037 · Cited by 4
Chapter 23. New Potential Therapies for the Treatment of Atherosclerosis
Larsen, S. D., & Spilman, C. H. (1993) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60893-3 · Cited by 4
고초균에 의한 탈지대두 grits 발효물의 항혈전 및 콜레스테롤 저하 효과
이성규, Kim, H. J., 임남경, 이은주, 이삼빈, & 이인선 (2009) · Korean Journal of Food Science and Technology · Cited by 4
Induction of Low-Density Lipoprotein Catabolism in Hep G2 Cells by a Fungal Sesquiterpene Ester, FR111142
Harada, T., Hasumi, K., & Endo, A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9564 · Cited by 4
Self-citation
Effect of onion (Allium cepa) ultra-high pressure processing and hot water extracts on the serum cholesterol level in high cholesterol-fed rats
Jung, H.-J., Wee, J., Kim, K., Sung, H.-M., & Shin, H. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0038-7 · Cited by 4
Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
Hajri, T., Chanussot, F., Férézou, J., Riottot, M., Lafont, H., Laruelle, C., & Lutton, C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00882-5 · Cited by 4
Effect of lifibrol on the metabolism of low density lipoproteins and cholesterol
Vega, G. L., von Bergmann, K., Grundy, S. M., Blumenschein, S. D., Carter, N. B., Laeis, P., Lindenthal, B., Bergmann, J. V., Simatupang, A., Lütjohann, D., et al. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00536.x · Cited by 4
Treatment - Drug Therapy
Teramoto, T., Sasaki, J., Ueshima, H., Egusa, G., Kinoshita, M., Shimamoto, K., Daida, H., Biro, S., Hirobe, K., Funahashi, T., et al. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e619 · Cited by 4
Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect
Mabuchi, H., Nohara, A., Kobayashi, J., Kawashiri, M., & Inazu, A. (2007) · Current Drug Therapy · doi:10.2174/157488507779422338 · Cited by 4
Lipid-modifying therapy
(2007) · CRC Press eBooks · doi:10.1201/b13464-10 · Cited by 4
Efficacy and safety of simvastatin in current clinical practice: the italian family physician simvastatin study
Cattin, L., Col, P. G. D., Bordin, P., Battello, C., Petrucco, A., & Fonda, M. (1996) · Current Therapeutic Research · doi:10.1016/s0011-393x(96)80050-6 · Cited by 4
GlcNAc Conjugated Atorvastatin with Enhanced Water Solubility and Cellular Internalization
Zhang, X., Chen, X., Zhao, W., Zeng, C., Luo, X. L., Li, W., Li, B., Jiang, J., & Dong, Y. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00295 · Cited by 4

Authors: Endo, A.
Corresponding author: Endo, A
ORCID: Endo, A
Venue: Journal of Lipid Research
Publisher: Elsevier BV
Published: 1992-11
Volume: 33
Issue: 11
Pages: 1569-1582
ISSN: 0022-2275 (ISSN-L)
DOI: 10.1016/s0022-2275(20)41379-3
OpenAlex: W2148463229
Cited by: 847
References: 114
Citations by year: 2026: 11 · 2025: 19 · 2024: 31 · 2023: 22 · 2022: 25 · 2021: 26 · 2020: 23 · 2019: 20 · 2018: 35 · 2017: 28 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 43 · 2012: 35
FWCI: 16.13
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 10200 d)
Locations: Journal of Lipid Research (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
Keywords: statins, cholesterol-lowering drugs, drug discovery, drug development
MeSH terms: Animals, Anticholesteremic Agents, Humans, Hypercholesterolemia, Lovastatin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, History, 20th Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The discovery and development of HMG-CoA reductase inhibitors.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks